Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,239,099
+$11,767,170 QoQ
Shares Held
1,001,598
+119.9% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. CGEM ranks #121 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,239,099 1,001,598
2026-03-31 $6,471,929 455,449
2025-12-31 $7,471,292 721,864
2025-09-30 $5,834,882 983,960
2025-06-30 $5,287,098 702,138
2025-03-31 $4,912,603 648,957
2024-12-31 $8,347,854 685,374
2024-09-30 $11,727,239 700,552
2024-06-30 $7,896,604 452,787
2024-03-31 $2,886,013 169,367
2023-12-31 $1,307,529 128,315
2023-09-30 $779,303 86,111
2023-06-30 $1,091,353 101,427
2023-03-31 $1,839,558 179,820
2022-12-31 $1,771,238 167,890
2022-09-30 $4,188,934 326,750
2022-06-30 $2,119,261 165,309
2022-03-31 $875,825 83,651
2021-12-31 $1,240,586 80,401
2021-09-30 $3,554,797 157,501
2021-06-30 $318,089 12,353
2021-03-31 $2,336,020 56,060